Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2019

01-11-2019 | Diabetic Retinopathy | Original Article

The effect of geodemographic factors on the attendance rates at a regional diabetic retinopathy treatment centre

Authors: Emily Greenan, Marisa Salim, Daniel Nicholas Coakley, Mark James

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2019

Login to get access

Abstract

Aim

To determine whether geodemographic factors, specifically age, gender or commuting distance, affect the attendance rates of patients referred to a Diabetic Retinopathy Treatment (DRT) Centre from the Irish National Diabetic Retinal Screening (DRS) Programme.

Methods

A retrospective analysis of the first 1200 patients who were referred for ophthalmic assessment between November 2013 and June 2015 to Cork University Hospital’s (CUH) DRT clinic from the DRS was completed.

Results

A total of 972 (81%) patients attended all their scheduled DRT appointments. The attendance rates for those living in counties Cork and Kerry were 83.9% and 72.5%, respectively. Fifty-seven (4.75%) patients failed to attend any of their clinic appointments (2.2% of Cork and 11.8% of Kerry referrals). Patients living within 60 km of the treatment centre were more likely to attend (p = 0.013). Both age and gender were also shown to have a statistically significant impact on attendance, with those under 40 years of age (p < 0.001) and male patients (p = 0.02) less likely to attend their scheduled appointments.

Conclusion

This study suggests a correlation between geodemographic factors (age, gender and commuting distance) and attendance at a DRT Centre. The longer commuting distance for Kerry patients contributes to their higher non-attendance rates indicating a need to provide a Kerry-based satellite treatment centre to improve accessibility.
Literature
1.
go back to reference Mortality and Causes of Death Collaborators (2015) Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet 385(2013):117–171 GBD Mortality and Causes of Death Collaborators (2015) Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet 385(2013):117–171 GBD
2.
go back to reference Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–2223CrossRef Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–2223CrossRef
3.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes; estimates for the year 2000 and projections for 2030. Diabetes Care 27(5):1047–1053CrossRef Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes; estimates for the year 2000 and projections for 2030. Diabetes Care 27(5):1047–1053CrossRef
5.
go back to reference Rhatigan MC, Leese GP, Ellis J, Ellingford A, Morris AD, Newton RW, Roxburgh ST (1999) Blindness in patients with diabetes who have been screened for eye disease. Eye 13:166–169CrossRef Rhatigan MC, Leese GP, Ellis J, Ellingford A, Morris AD, Newton RW, Roxburgh ST (1999) Blindness in patients with diabetes who have been screened for eye disease. Eye 13:166–169CrossRef
6.
go back to reference Cormack TG, Grant B, Macdonald MJ, Steel J, Campbell IW (2001) Incidence of blindness due to diabetic eye disease in Fife 1990-9. Br J Ophthalmol 85:354–356CrossRef Cormack TG, Grant B, Macdonald MJ, Steel J, Campbell IW (2001) Incidence of blindness due to diabetic eye disease in Fife 1990-9. Br J Ophthalmol 85:354–356CrossRef
7.
go back to reference NHS Centre for Reviews and Dissemination, University of York (1999) Complications of diabetes: screening for retinopathy, management of foot ulcers. Effective Health Care 5(4):1–12 NHS Centre for Reviews and Dissemination, University of York (1999) Complications of diabetes: screening for retinopathy, management of foot ulcers. Effective Health Care 5(4):1–12
8.
go back to reference Kelliher C, Kenny D, O’Brien C (2006) Trends in blind registration in the adult population of the Republic of Ireland 1996-2003. Br J Ophthalmol 90:367–371CrossRef Kelliher C, Kenny D, O’Brien C (2006) Trends in blind registration in the adult population of the Republic of Ireland 1996-2003. Br J Ophthalmol 90:367–371CrossRef
9.
go back to reference Tracey ML, McHugh SM, Fitzgerald AP, Buckley CM, Canavan RJ, Kearney PM (2016) Trends in blindness due to diabetic retinopathy among adults aged 18-69 years over a decade in Ireland. Diabetes Res Clin Pract 121:1–8CrossRef Tracey ML, McHugh SM, Fitzgerald AP, Buckley CM, Canavan RJ, Kearney PM (2016) Trends in blindness due to diabetic retinopathy among adults aged 18-69 years over a decade in Ireland. Diabetes Res Clin Pract 121:1–8CrossRef
10.
go back to reference Jönsson B (2002) Revealing the cost of type II diabetes in Europe. Diabetologia 45(7):5–12CrossRef Jönsson B (2002) Revealing the cost of type II diabetes in Europe. Diabetologia 45(7):5–12CrossRef
11.
go back to reference Association AD (2013) Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36(4):1033–1046CrossRef Association AD (2013) Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36(4):1033–1046CrossRef
12.
go back to reference National Council for the Blind of Ireland (2011) The cost of sight loss: the economic impact of vision impairment and blindness in the Republic of Ireland. NCBI Publications, Dublin National Council for the Blind of Ireland (2011) The cost of sight loss: the economic impact of vision impairment and blindness in the Republic of Ireland. NCBI Publications, Dublin
13.
go back to reference Wilson JMG, Jungner G. Principles and practice of screening for disease. Public health paper number 34. Geneva: WHO, 1968 Wilson JMG, Jungner G. Principles and practice of screening for disease. Public health paper number 34. Geneva: WHO, 1968
14.
go back to reference National Institute for Health and Clinical Excellence. (2008) Type 2 diabetes; management of type 2 diabetes. Clinical guidelines CG66. London; NICE National Institute for Health and Clinical Excellence. (2008) Type 2 diabetes; management of type 2 diabetes. Clinical guidelines CG66. London; NICE
15.
go back to reference American Diabetes Association (2002) Diabetic retinopathy. Diabetes Care 25(suppl 1):s90–s93 American Diabetes Association (2002) Diabetic retinopathy. Diabetes Care 25(suppl 1):s90–s93
16.
go back to reference Bachmann MO, Nelson S. (1996) Screening for diabetic retinopathy: a quantitative overview of the evidence, applied to the populations of health authorities and boards. Health Care Evaluation Unit, Department of Social Medicine: University of Bristol Bachmann MO, Nelson S. (1996) Screening for diabetic retinopathy: a quantitative overview of the evidence, applied to the populations of health authorities and boards. Health Care Evaluation Unit, Department of Social Medicine: University of Bristol
17.
go back to reference Javitt JC, Atello LP (1996) Cost effectiveness of determining and treating diabetic retinopathy. Ann Intern Med 124:164–169CrossRef Javitt JC, Atello LP (1996) Cost effectiveness of determining and treating diabetic retinopathy. Ann Intern Med 124:164–169CrossRef
18.
go back to reference World Health Organisation (Europe), International Diabetes Foundation (Europe) (1990) Diabetes care and research in Europe: the St. Vincent declaration. Diabet Med 7(4):360CrossRef World Health Organisation (Europe), International Diabetes Foundation (Europe) (1990) Diabetes care and research in Europe: the St. Vincent declaration. Diabet Med 7(4):360CrossRef
19.
go back to reference Gray RH, Blades C, Jobson T (2009) Screening clinic non-attendance and the risk of sight threatening retinopathy. 19th meeting of the European Association for the study of diabetes eye complications study group (EASDec), Oxford, pp 22–24 Gray RH, Blades C, Jobson T (2009) Screening clinic non-attendance and the risk of sight threatening retinopathy. 19th meeting of the European Association for the study of diabetes eye complications study group (EASDec), Oxford, pp 22–24
20.
go back to reference Zoega GM, Gunnarsdottir T, Bjornsdottir S et al (2005) Screening compliance and visual outcome in diabetes. Acta Ophthalmol Scand 83(6):687–690CrossRef Zoega GM, Gunnarsdottir T, Bjornsdottir S et al (2005) Screening compliance and visual outcome in diabetes. Acta Ophthalmol Scand 83(6):687–690CrossRef
21.
go back to reference Waqar S, Bullen G, Chant S, Salman R, Vaidya B, Ling R (2012) Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme. Diabetes Metab Syndr Clin Res Rev 6:199–202CrossRef Waqar S, Bullen G, Chant S, Salman R, Vaidya B, Ling R (2012) Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme. Diabetes Metab Syndr Clin Res Rev 6:199–202CrossRef
22.
go back to reference GP Leese A, Emslie-Smith PB, Ellis JD, Feng Z (2008) Screening uptake in a well established diabetic retinopathy screening program. Diabetes Care 31(11):2131–2135CrossRef GP Leese A, Emslie-Smith PB, Ellis JD, Feng Z (2008) Screening uptake in a well established diabetic retinopathy screening program. Diabetes Care 31(11):2131–2135CrossRef
23.
go back to reference Millett C, Dodhia H (2006) Diabetes retinopathy screening: audit of equity in participation and selected outcomes in South East London. Med Screen 13:152–155CrossRef Millett C, Dodhia H (2006) Diabetes retinopathy screening: audit of equity in participation and selected outcomes in South East London. Med Screen 13:152–155CrossRef
25.
go back to reference Scanlon PH, Stratton IM, Leese GP, Bachmann MO, Land M, Jones C, Ferguson B, the Four Nations Diabetic Retinopathy Screening Study Group (2016) Four nations diabetic retinopathy screening study group. Screening attendance, age group and diabetic retinopathy level at first screen. Diabet Med 33(7):904–911CrossRef Scanlon PH, Stratton IM, Leese GP, Bachmann MO, Land M, Jones C, Ferguson B, the Four Nations Diabetic Retinopathy Screening Study Group (2016) Four nations diabetic retinopathy screening study group. Screening attendance, age group and diabetic retinopathy level at first screen. Diabet Med 33(7):904–911CrossRef
26.
go back to reference Dervan E, Lillis D, Flynn L, Staines A, O’Shea D (2008) The factors that influence the patient uptake of diabetic retinopathy screening. Ir J Med Sci 177:303–308CrossRef Dervan E, Lillis D, Flynn L, Staines A, O’Shea D (2008) The factors that influence the patient uptake of diabetic retinopathy screening. Ir J Med Sci 177:303–308CrossRef
27.
go back to reference Keenum Z, McGwin G Jr, Witherspoon CD, Haller JA, Clark ME, Owsley C (2016) Patients’ adherence to recommended follow-up eye care after diabetic retinopathy screening in a publicly funded county clinic and factors associated with follow-up eye care use. JAMA Ophthalmol 134(11):1221–1228CrossRef Keenum Z, McGwin G Jr, Witherspoon CD, Haller JA, Clark ME, Owsley C (2016) Patients’ adherence to recommended follow-up eye care after diabetic retinopathy screening in a publicly funded county clinic and factors associated with follow-up eye care use. JAMA Ophthalmol 134(11):1221–1228CrossRef
28.
go back to reference Maxwell AJ (2000) Relocation of a static breast screening unit: a study of factors affecting attendance. J Med Screen 7(2):114–115CrossRef Maxwell AJ (2000) Relocation of a static breast screening unit: a study of factors affecting attendance. J Med Screen 7(2):114–115CrossRef
29.
go back to reference Bennett GH, Tuthill A (2017) Investigating the barriers to the uptake of Diabetic RetinaScreen. Ir Med J 110(9):814–821 Bennett GH, Tuthill A (2017) Investigating the barriers to the uptake of Diabetic RetinaScreen. Ir Med J 110(9):814–821
30.
go back to reference Robotham D, Satkunanathan S, Reynolds J, Stahl D, Wykes T (2016) Using digital notifications to improve attendance in clinic: systematic review and meta-analysis. BMJ Open 6(10):e012116CrossRef Robotham D, Satkunanathan S, Reynolds J, Stahl D, Wykes T (2016) Using digital notifications to improve attendance in clinic: systematic review and meta-analysis. BMJ Open 6(10):e012116CrossRef
Metadata
Title
The effect of geodemographic factors on the attendance rates at a regional diabetic retinopathy treatment centre
Authors
Emily Greenan
Marisa Salim
Daniel Nicholas Coakley
Mark James
Publication date
01-11-2019
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2019
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-019-02009-4

Other articles of this Issue 4/2019

Irish Journal of Medical Science (1971 -) 4/2019 Go to the issue